Dr. Dave is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 Michigan Ave NW
300-W
Washington, DC 20010Phone+1 202-476-5000Fax+1 202-476-5685
Clinical Expertise
- Immunotherapy, Bone marrow transplantation, Lymphoma, Pediatric hematology and oncology, Leukemia, Pediatric bone marrow transplantation
Education & Training
- Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2008 - 2011
- Johns Hopkins UniversityResidency, Pediatrics, 2006 - 2008
- Wayne State University School of MedicineInternship, Transitional Year, 2005 - 2006
- University of MassachusettsMPH, 2003 - 2005
- L. Tilak Municipal Medical CollegeClass of 2003
Certifications & Licensure
- DC State Medical License 2012 - 2024
- MD State Medical License 2008 - 2012
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Children's Cancer Foundation Grant Children's Cancer Foundation
- Translational Research Program Grant Leukemia Lymphoma Society, 2017-2020
- Scholar Award American society of HematologyScholar, 2018
- Join now to see all
Clinical Trials
- Tumor Associated Antigen Specific T Cells (TAA-T) With PD1 Inhibitor for Lymphoma Start of enrollment: 2019 Jun 24
Publications & Presentations
PubMed
- 13 citationsNovel TCR-like CAR-T cells targeting an HLA∗0201-restricted SSX2 epitope display strong activity against acute myeloid leukemia.Scott Raskin, Stacey Van Pelt, Keri Toner, Preethi Bala Balakrishnan, Hema Dave
Molecular Therapy. Methods & Clinical Development. 2021-12-10 - 11 citationsEngineering cord blood to improve engraftment after cord blood transplantRohtesh S. Mehta, Hema Dave, Catherine M. Bollard, Elizabeth J. Shpall
Stem Cell Investigation. 2017-05-25 - 1 citationsRobust immune responses to SARS-CoV-2 in a pediatric patient with B-Cell ALL receiving tisagenlecleucel.Oren M Gordon, Madeline Terpilowski, Robin Dulman, Michael D Keller, Peter D Burbelo
Pediatric Hematology and Oncology. 2022-09-01
Journal Articles
- Sickle Cell EmergenciesDave H, Pecker L, Pediatric Emergency Medicine Reports, 1/1/2015
- The Role of Screening Sinus CT in pediatric hematopoietic stem cell transplant recipientsZamora C, Oppenheimer A, Dave H, Huisman T, Symons H and Izbudek I, Journal of Computed Tomography, 1/1/2014
- Immunotherapy for Pediatric LeukemiaShah NN, Dave H, Wayne AS, Frontiers in Oncology, 1/1/2013
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Multi-virus specific cytotoxic T cells to combat CMV,EBV, Adenovirus and BK viral infections after cord blood transplantationDave H, Luo M, Cruz R and Bollard C, Children’s National Health System’s Research and education week, 1/1/2016
- Voriconazole metabolism is influenced by ethnicity: one size does not fit allDave H, Williams D, Bollard C and Williams K, 28th Annual meeting of The American Society of Pediatric Hematology and Oncology, Phoenix, AZ, 1/1/2015
- Biopsy identifies CD20+ B cells as potential mediators of minimal change nephrotic syndrome chronic GVHDDave, H, McLaughlin L, Schore R, Mistry K and Williams K, 28th Annual meeting of The American Society of Pediatric Hematology and Oncology, Phoenix, AZ, 1/1/2015
- Join now to see all
Professional Memberships
- Member
- Children's Oncology GroupMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: